Healthcare focused investment firm HealthQuad, backed by Quadria Group, has announced a strategic investment in LifeSigns, an India based AI-powered remote patient monitoring platform. The investment is aimed at accelerating the company’s international expansion and strengthening its predictive healthcare technology capabilities.
LifeSigns has developed an integrated patient monitoring ecosystem that combines US FDA-approved wearable devices, cloud-based dashboards, and AI-powered predictive analytics. The platform continuously monitors patient vitals such as ECG, heart rate, respiration, oxygen saturation, blood pressure, and temperature across ambulances, emergency rooms, ICUs, wards, and even home care environments.
According to company data reported across multiple sources, the AI engine can detect early signs of patient deterioration up to 26 hours in advance and identify critical risk scenarios within a four hour window. The system has reportedly generated more than 87,000 life saving alerts across over 50 hospitals in India, helping reduce ICU readmissions by nearly 78% and code blue emergencies by close to 90%.
HealthQuad described the investment as a “high conviction bet” on the future of continuous and predictive healthcare. The firm stated that healthcare systems globally are shifting away from episodic monitoring toward real time, AI-assisted care because of rising patient volumes, workforce shortages, and increasing healthcare costs.
As LifeSigns’ first institutional investor, HealthQuad plans to support the company’s global expansion into Southeast Asia and Gulf Cooperation Council (GCC) markets through Quadria’s international healthcare network. The partnership will also focus on strengthening LifeSigns’ AI stack through advanced integrations and predictive intelligence tools.
The latest investment follows earlier strategic funding received from Healthcare Capital, the investment arm of the Kauvery Hospital Group, in 2025. That funding round was primarily aimed at improving LifeSigns’ AI algorithms and expanding its real time patient monitoring infrastructure.
Industry experts believe remote patient monitoring is becoming one of the fastest-growing segments in digital healthcare. Reports estimate the global remote patient monitoring devices market has already crossed $26 billion in 2025 as hospitals increasingly adopt AI-driven monitoring systems to improve patient safety, reduce hospital burden, and support preventive care models.
Healthcare analysts also note that India is emerging as a major innovation hub for affordable AI-powered healthcare solutions, particularly in areas such as remote monitoring, telemedicine, predictive diagnostics, and digital hospital infrastructure. LifeSigns’ occupancy-based pricing model and deployment strategy in tier-2 and tier-3 cities are viewed as key factors helping improve healthcare accessibility beyond metro regions.
“No patient should deteriorate silently because systems are not designed to continuously monitor them.”
By
HB Team
